Registry of outcomes for the Vercise DBS System in Parkinson's disease

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This registry aims to compile worldwide outcomes from the use of the Vercise Deep Brain Stimulation (DBS) System by Boston Scientific in treating Parkinson's disease. It evaluates the effectiveness of the system in improving disease symptoms and overall quality of life, comparing results to baseline measurements. The study also assesses the use of Image Guided Programming (IGP) and the DBS Illumina 3D feature as planning tools for patient programming. By gathering data from various locations, the registry seeks to provide a comprehensive overview of the system's performance.

Why it matters

Who can join: the full rules

Key Inclusion Criteria:

* Meets criteria established in locally applicable Vercise System Direction for Use
* At least 18 years old

Key Exclusion Criteria:

* Meets any contraindication in the Vercise System locally applicable Directions for Use

Subjects with significant cognitive or psychiatric impairment may be excluded in the evaluation of GXT.

Where it's running

• Cedars Sinai Medical Center
  Los Angeles, California, United States Recruiting
• University of Colorado
  Aurora, Colorado, United States Recruiting
• St. Mary's Hospital and Medical Center
  Grand Junction, Colorado, United States Recruiting
• University of Florida Shands Hospital
  Gainesville, Florida, United States Recruiting
• University of Miami Hospital
  Miami, Florida, United States Recruiting
• University of South Florida
  Tampa, Florida, United States Recruiting

+37 more sites. See ClinicalTrials.gov for the full list.

Study contacts

• Study coordinator: Heleen Scholtes
• Email: BSNClinicalTrials@bsci.com
• Phone: 855-213-9890

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Ginger as a Modifier of Ghrelin Levels in Parkinson’s Disease and REM Sleep Behavior Disorder

  This study tests whether ginger capsules can raise ghrelin levels in people with Parkinson’s disease, REM sleep behavior disorder, and healthy controls.

  Recruiting Cambridge University Hospitals NHS Foundation Trust · Cambridge · NCT07882108

• Intraoperative Microelectrode Recordings with MAVEN vs Standard Equipment

  This study tests whether MAVEN can match the recording data collected during DBS surgery for movement disorders using standard equipment.

  Recruiting Mayo Clinic · Rochester, Minnesota · NCT07868614

• Mental imagery with self-regulation to help daily activities in Parkinson's disease

  This study tests whether a six-week program of mental imagery combined with self-regulation can help people with Parkinson’s perform daily activities better than standard learning or exercise.

  Recruiting The Hong Kong Polytechnic University · Hong Kong · NCT07860294

• Real-world experiences of Inbrija for Parkinson's OFF episodes

  This study looks at how people with Parkinson’s who use Inbrija for OFF episodes feel and function in daily life.

  Recruiting Merz Pharmaceuticals GmbH · Altmünster and 1 other locations · NCT07797790

• Gut methane and Parkinson's: measuring if a probiotic helps people with Parkinson's, REM sleep behavior disorder, or cognitive concerns

  This study tests whether a probiotic containing Limosilactobacillus reuteri can help people with Parkinson's disease, those at high risk for PD, and related cognitive issues by potentially improving gut methane levels and overall symptoms.

  Recruiting University of Cambridge · Cambridge, CB2 · NCT07786116

• Test of RO7568282 in early Parkinson's disease

  This study tests whether RO7568282, compared with placebo, is safe and helps people with early Parkinson's disease who are already taking levodopa.

  Recruiting at 4 sites Phase 2 Hoffmann-La Roche · Boca Raton, Florida and 3 other locations · NCT07781644

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.